Friday, 14 December 2018

News & Events

10 December 2018

7th General Assembly & 4th Investigators Meeting

On 18th and 19th December 2018 the 7th General Assembly and 4th Investigators meeting of NeoVanc project will take place in Athens, Greece. Hosted by PENTA partner CLEO (cleoresearch.org/en), the gathering will chiefly focus on consolidating the…
4 September 2018

Over 50% of patients now enrolled!

We are delighted to bring you the news that successful randomisation of over 50% of NeoVanc’s target has been achieved. Congratulations to all the NeoVanc team on hitting this momentous milestone and for your on-going hard work and commitment to the…
20 February 2018

We reached 103 randomised patients!

We are thrilled to congratulate all the NeoVanc Investigators and Co-Investigators for having reached (and exceeded) the important milestone of 100 children enrolled! The effort they have put so far in the NeoVanc project has been essential in…
13 December 2017

The 3rd Investigators Meeting will take place in Barcelona - Spain on 13th December 2017

The program and information about the venue and logistics will be available soon. We look forward to meeting you in Barcelona!
19 September 2017

Patient No. 50 has been enrolled into the study.

We are proud to announce that our milestone of 50 patients has been reached. Congratulations to all recruiting sites for this remarkable result!
24 May 2017

The 2nd Investigators Meeting took place in Madrid on 24th May 2017

The meeting was a success. Many thanks to all participants for their active contribution.
13 May 2016

The 4th Consortium Meeting (NGC) and 1st Investigators Meeting will take place in Rome on the 6th and 7th June 2016

The 4th Consortium Meeting (NGC) and 1st Investigators Meeting will take place in the beautiful city of Rome on the 6th and 7th June 2016 We look forward to seeing you!

Login:

Reserved Access to the our services for our Partners.

Copyright © NeoVanc | All rights reserved. Read the disclaimer.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no: 602041
Call: FP7-HEALTH-2013-INNOVATION-1
Privacy policy | Terms and conditions

E-mail: info@penta-id.org